Parmax Pharma Ltd — Board Meeting, 21-05-2025: Board Meeting

Parmax Pharma Limited has announced a board meeting to approve the audited financial results for the quarter and financial year ended 31 March 2025. The company has also instituted a trading window closure effective immediately until 48 hours after the results are publicly announced. This update is important for shareholders as it signals upcoming financial disclosures and ensures compliance with insider trading norms.